Fundz

Ceretype Neuromedicine

Cambridge, United States · Biotechnology · 7 employees

Ceretype has pioneered the integration of fMRI into therapeutic applications in neuropsychiatry. Our uniquely scalable platform makes targeted biomarkers accessible, delivering actionable insights for our pharma/biotech partners. Our decades of expertise across neuromedicine, brain imaging, and industry processes enables innovations that will ultimately transform patient care.

Funding history

  • Seed — $400K — Dec 2025
  • Seed — Undisclosed — Jan 2024
  • Seed — $1.4M — Nov 2021

Recent signals

  • Dec 18, 2025: Raised $400K in Seed
  • Jan 04, 2024: Raised funding in Seed
  • Nov 22, 2021: Raised $1.4M in Seed

See plans & pricing → Track Ceretype Neuromedicine’s funding, hiring, and signals — with verified contacts — on Fundz.